Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of olanzapine on endogenous glucose production.

E.M. Girault, E. Foppen, M.T. Ackermans, E. Fliers, A. Kalsbeek

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)238-245
JournalBrain Research
Volume1527
DOIs
Publication statusPublished - 2013

Cite this